Aging increases cytochrome P450 4A modulation of α1-adrenergic vasoconstriction in mesenteric arteries

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 3, 2008, Pages 327-330

  Berezan, Dellice J ^a   Dunn, Kathryn M J ^b   Falck, John R ^c   Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

20 HETE; Aging; CYP4A; Mesenteric arteries; Rat; Vasoconstriction

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOCHROME P450 4A; ENDOTHELIN 1;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; AGING; ALKANE 1-MONOOXYGENASE; AMIDES; ANIMALS; ENDOTHELIN-1; HYDROXYEICOSATETRAENOIC ACIDS; MALE; MESENTERIC ARTERIES; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; SULFONES; VASOCONSTRICTION;

EID: 41349084425     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318160b415     Document Type: Article

References (23)

1. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 2002;82:131-185.
2. Zhang F, Wang MH, Krishna UM, et al. Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 2001;38:1311-1315.
3. Roman RJ, Lombard JH. Does 20-hydroxyeicosatetraenoic acid contribute to sex differences in cardiovascular risk by increasing oxidative stress? Hypertension. 2007;50:37-38.
4. Wang MH, Zhang F, Marji J, et al. CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol Regul Integr Comp Physiol. 2001;280:R255-R261.
5. Zhang F, Chen CL, Qian JQ, et al. Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase. Cell Res. 2005;15:717-724.
6. Wang JS, Singh H, Zhang F, et al. Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res. 2006;98:962-969.
7. Oyekan A, Balazy M, McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol. 1997;273:R293-R300.
8. Goettsch W, Lattmann T, Amann K, et al. Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem Biophys Res Commun. 2001;280:908-913.
9. Sullivan JC, Davison CA. Gender differences in the effect of age on electrical field stimulation (EFS)-induced adrenergic vasoconstriction in rat mesenteric resistance arteries. J Pharmacol Exp Ther. 2001;296:782-788.
10. Hemmings DG, Williams SJ, Davidge ST. Increased myogenic tone in 7-month-old adult male but not female offspring from rat dams exposed to hypoxia during pregnancy. Am J Physiol Heart Circ Physiol. 2005;289:H674-H682.
11. Williams JM, Sharma M, Anjaiahh S, et al. Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier. Am J Physiol Renal Physiol. 2007.
12. Kroetz DL, Huse LM, Thuresson A, et al. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Mol Pharmacol. 1997;52:362-372.
13. Omata K, Abraham NG, Escalante B, et al. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol. 1992;262:F8-F16.
14. Ruan Y, Kan H, Parmentier JH, et al. Alpha-1A adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase D in rat-1 fibroblasts: inhibition by protein kinase A. J Pharmacol Exp Ther. 1998;284:576-585.
15. Imig JD, Zou AP, Stec DE, et al. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 1996;270:R217-R227.
16. Zou AP, Fleming JT, Falck JR, et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol. 1996;270:R228-R237.
17. Gebremedhin D, Lange AR, Narayanan J, et al. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J Physiol. 1998;507(Pt 3):771-781.
18. Toro L, Marijic J, Nishimaru K, et al. Aging, ion channel expression, and vascular function. Vascul Pharmacol. 2002;38:73-80.
19. Resink TJ, Scott-Burden T, Buhler FR. Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1989;158:279-286.
20. Resink TJ, Scott-Burden T, Buhler FR. Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1988;157:1360-1368.
21. Hercule HC, Oyekan AO. Cytochrome P450 omega/omega-1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole. J Pharmacol Exp Ther. 2000;292:1153-1160.
22. Vanhoutte PM, Mombouli JV. Vascular endothelium: vasoactive mediators. Prog Cardiovasc Dis. 1996;39:229-238.
23. Imig JD, Pham BT, LeBlanc EA, et al. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses. Hypertension. 2000;35:307-312.